Mizuho maintains Outperform on MiniMed Group; price target raised
Mizuho maintained its Outperform rating on MiniMed Group and raised its price target to $26.00 per share from $21.00.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.